CD8A and neoplasm: As the general immunosuppressive activities of TDEVs involve the polarization of TAMs toward the M2 phenotype, suppression of CD8+ T cells, and modulation of DC function, therapies inhibiting the secretion of TDEVs from tumor cells may be one potential strategy to restore anti-tumor immunity (221, 222).